MedPath

TC-WYRE: TAXUS Express Stent vs. Cypher Stent - What's Your Real Life Experience?

Not Applicable
Completed
Conditions
Coronary Artery Disease
Registration Number
NCT00344630
Lead Sponsor
Boston Scientific Corporation
Brief Summary

To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine performance of the two stents in pre-specified subgroup populations and examine regional and national patterns in outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • Patients treated with a TAXUS Express2 stent or a Cypher stent between April 1, 2005 and June 30, 2005.
Exclusion Criteria
  • Simultaneous treatment with both TAXUS and Cypher stents during the index revascularization. Patients who have undergone previous target vessel(s), stenting procedure within 9 months of the index procedure will be excluded.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Duke University

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath